New Delhi: Alkem Laboratories Limited has issued a corporate guarantee of 54.45 million Euros to HSBC UK Bank plc for a 49.5 Euros million term loan availed by its step-down subsidiary, Occlutech Holding AG, in Switzerland.

According to the company, the corporate guarantee has been issued to HSBC UK Bank plc for the term loan of €49.5 million availed by Occlutech Holding AG.

Alkem said that the promoter, promoter group and group companies do not have any interest in the transaction and that the corporate guarantee has been issued at arm’s length.

The company stated that the guarantee represents a contingent liability, under which Alkem Laboratories would have to make payment in the event of a default by Occlutech.

Occlutech Holding AG is a step-down subsidiary of Alkem Laboratories based in Switzerland.

Also Read: Alkem Labs' Daman Facility Gets 7 USFDA Observations, Classified as OAI

Alkem has established manufacturing and research capabilities supporting the development and production of pharmaceutical formulations and active pharmaceutical ingredients. Its operations include manufacturing facilities and research and development activities associated with pharmaceutical product development.

The company has also developed an international business with products marketed across various global markets. Its operations outside India form part of its broader pharmaceutical business, with the company supplying medicines across multiple therapeutic categories.

Also Read: Alkem Labs Slapped with Rs 333 Crore Tax Demand, Plans Appeal

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .